From Classic to Atypical CIDP: A Guide to Symptoms and Treatments

Living with my Lewis Sumner Syndrome condition is trying to understand what I am up against, and all I can tell for sure it is not easy.

CIDP is still, for the most part, a “mystery illness” for me due to its fluctuating symptoms, their varied intensity, weird sensations they cause in my body, and the constrains they impose.

The limitations from CIDP in my daily life; for instance, I can still drive my car and hang the laundry, but I have to keep my nails short, my hairstyle & makeup as simple as possible, and when I cook I need to chop and slice with care so I won’t cut my fingers off.

When I’m in a restaurant, my symptoms often dictate what I order—because not all foods are CIDP-friendly. Try eating a rich, messy burger during a flare-up… not the prettiest sight. I honestly can’t even remember the last time I ate with a knife and fork.

Some might say I should be grateful that my right arm and hand are still working—and sure, I am. But here’s the kicker: because my left side is so limited, my right arm ends up doing all the heavy lifting, quite literally. As a result, it often aches from overuse. So while it still works, it’s not exactly living its best life either.

I can’t help but feel relieved that I’m not a surgeon, a cook, or a pianist—I’d definitely be out of work in those professions.

And that’s just a part of it because I don’t want to even start on Chronic Fatigue Syndrome it loves to pair with… that is a whole other story…

Anyway, while a bit of complaining does offer some mental relief—and proudly confirms my Polish roots—there’s also a part of me that’s genuinely curious. I want to understand this puzzle that is CIDP, not just live with it. So I’ve been digging, reading, asking questions—and here’s what I’ve found out so far.

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

is an immune-mediated neurological disorder characterized by progressive weakness and sensory dysfunction due to demyelination of peripheral nerves. CIDP encompasses several variants, each with distinct clinical features, symptoms, and treatment responses. Below is a detailed list of the known CIDP variants, their symptoms, and treatment approaches.

Variants of CIDP, Symptoms, and Treatments

1. Classic Sensorimotor CIDP (Typical CIDP)

• Symptoms:
  • Symmetric weakness affecting both proximal and distal muscles, especially around hips, shoulders, hands, and feet.
  • Sensory deficits such as numbness, tingling, and loss of proprioception and vibration sense.
  • Reduced or absent deep tendon reflexes.
  • Symptoms develop gradually over at least 8 weeks.
  • Patients may experience balance problems and frequent falls.
• Treatment:
  • First-line therapies include corticosteroids, intravenous immunoglobulin (IVIg), and plasma exchange.
  • Immunosuppressants may be used if first-line treatments are insufficient.
  • Physical and occupational therapy for rehabilitation.
• Notes:
  • This is the most common form, accounting for about 50% or more of cases.

2. Pure Motor CIDP

• Symptoms:
  • Predominantly motor weakness without sensory abnormalities.
  • Muscle weakness can be symmetric or asymmetric.
  • Loss of reflexes.
• Treatment:
  • Similar immunotherapies as classic CIDP: IVIg, corticosteroids, plasma exchange.
  • Early treatment is important to prevent disability.
• Notes:
  • Accounts for up to 10% of CIDP cases.
  • May resemble other motor neuropathies such as multifocal acquired motor axonopathy (MAMA).

3. Pure Sensory CIDP (Sensory CIDP)

• Symptoms:
  • Sensory symptoms such as numbness, tingling, imbalance, and incoordination without muscle weakness.
  • May present with chronic immune sensory polyradiculopathy (CISP), a form with predominant sensory nerve root involvement.
  • Loss or reduction of deep tendon reflexes.
• Treatment:
  • Immunotherapy including IVIg has shown significant effectiveness; studies report improvement in about 88% of treated patients.
  • Corticosteroids and plasma exchange may also be used.
• Notes:
  • Sensory CIDP can be challenging to diagnose and is considered a distinct variant.
  • Patients respond well to immunotherapy.

4. Distal CIDP (Distal Acquired Demyelinating Symmetric Neuropathy – DADS)

• Symptoms:
  • Sensory and motor deficits predominantly in distal limbs (hands and feet).
  • Weakness and sensory loss do not typically involve proximal muscles.
  • Often associated with anti-myelin-associated glycoprotein (MAG) antibodies in about 70% of cases.
  • May be associated with IgM paraproteinemia (DADS-M subtype).
• Treatment:
  • IVIg and corticosteroids are used.
  • Treatment response may vary, especially in cases with IgM paraproteinemia.
• Notes:
  • Represents a distal, symmetric form of CIDP .

5. Multifocal CIDP (Lewis-Sumner Syndrome or MADSAM)

• Symptoms:
  • Asymmetric, multifocal sensory and motor deficits.
  • Weakness often affects distal muscles more than proximal.
  • Symptoms correspond to involvement of individual peripheral nerves.
  • Slow, progressive course.
• Treatment:
  • Immunotherapies such as IVIg and corticosteroids.
  • Plasma exchange in refractory cases.
• Notes:
  • Accounts for 6% to 15% of CIDP cases.
  • Sometimes considered a variant of CIDP with features overlapping mononeuropathies.

6. Focal CIDP

• Symptoms:
  • Deficits localized to one or a few nerves or nerve roots.
  • May present with focal weakness and sensory loss.
• Treatment:
  • Similar immunomodulatory treatments as other CIDP variants.
• Notes:
  • Less common and may be difficult to distinguish from other focal neuropathies1.

7. Chronic Immune Sensory Polyradiculopathy (CISP)

• Symptoms:
  • Predominantly sensory symptoms with involvement of sensory nerve roots.
  • Severe sensory ataxia and imbalance.
  • Minimal or no motor weakness.
• Treatment:
  • Immunotherapy including IVIg has been effective.
• Notes:
  • Considered a subtype of pure sensory CIDP with radiculopathy features.

Summary Table of CIDP Variants

Variant	Symptoms	Key Features	Treatment
Classic Sensorimotor CIDP	Symmetric proximal & distal weakness, sensory loss, areflexia	Most common, large-fiber neuropathy	IVIg, corticosteroids, plasma exchange, rehab
Pure Motor CIDP	Motor weakness without sensory loss	Up to 10% cases	IVIg, corticosteroids, plasma exchange
Pure Sensory CIDP (including CISP)	Sensory loss, imbalance, no weakness	Sensory nerve root involvement in CISP	IVIg, corticosteroids
Distal CIDP (DADS)	Distal symmetric sensory & motor deficits	Often anti-MAG antibodies, IgM paraprotein	IVIg, corticosteroids
Multifocal CIDP (MADSAM)	Asymmetric multifocal sensory & motor deficits	Distal muscles more affected	IVIg, corticosteroids, plasma exchange
Focal CIDP	Localized nerve involvement	Focal weakness and sensory loss	Immunotherapy
Chronic Immune Sensory Polyradiculopathy (CISP)	Severe sensory ataxia, sensory root involvement	Pure sensory, radiculopathy	IVIg, immunotherapy

General Treatment Principles for CIDP and Its Variants

• Immunotherapy is the mainstay: IVIg, corticosteroids, and plasma exchange are first-line treatments across variants.
• IVIg: Typically given as an initial loading dose (2 g/kg over 2-5 days) followed by maintenance doses every 4-8 weeks; subcutaneous immunoglobulin (SCIg) is an alternative.
• Corticosteroids: Used to reduce inflammation but long-term use has side effects.
• Plasma Exchange: Used in patients who do not respond to IVIg or steroids.
• Immunosuppressants: Considered in refractory cases.
• Rehabilitation: Physical and occupational therapy to improve function and mobility.
• Response to treatment: Most patients show improvement within weeks, but some may take months.

CIDP is a syndrome with multiple variants distinguished by the distribution and type of nerve involvement-sensorimotor, pure motor, pure sensory, distal, multifocal, focal, and CISP. Each variant presents with characteristic symptoms, but all share an immune-mediated demyelinating pathology. Treatment primarily involves immunomodulatory therapies such as IVIg, corticosteroids, and plasma exchange, tailored to the severity and variant of CIDP.

Conclusion

So what can I say…

Comes out that CIDP isn’t just one tidy diagnosis—it’s more like a collection of cousins at a chaotic family reunion. There are several variants, each showing up in its own quirky way: some affect both sensation and movement, others stick to motor or sensory nerves only. You might hear terms like distal, multifocal, focal, or even the oddly named CISP (because who doesn’t love a confusing acronym?).

Despite the differences, what they all have in common is an immune system that’s a little too enthusiastic—attacking the protective covering of nerves and causing all the trouble.

So, if you’re feeling like your body has turned into a medical mystery novel—you’re not alone.

It’s okay to feel overwhelmed, but don’t lose hope.

There are ways forward, and many of us are walking (or wobbling) that same path.

Be kind to yourself, stay curious, and remember: even a puzzle can be solved—one piece at a time.

---

Disclaimer: Everything shared here comes from my own journey with CIDP and is meant for reflection and support, not medical guidance—your healthcare team is always the best source for personal medical decisions.

SHARING IS CARING – IF THIS SUPPORTED YOU IN ANY SMALL WAY, SHARING IT MAY SUPPORT SOMEONE ELSE WITH CIDP, MMN, GBS, OR SIMILAR CONDITION, AND SUBSCRIBING KEEPS THIS CIRCLE AND AWARENESS GROWING

Citations:

1. https://www.rarediseaseadvisor.com/hcp-resource/chronic-inflammatory-demyelinating-polyneuropathy-types/
2. https://pmc.ncbi.nlm.nih.gov/articles/PMC8745770/
3. https://www.rarediseaseadvisor.com/hcp-resource/chronic-inflammatory-demyelinating-polyneuropathy-clinical-features/
4. https://www.webmd.com/brain/what-is-cidp
5. https://rarediseases.org/rare-diseases/chronic-inflammatory-demyelinating-polyneuropathy/
6. https://www.knightneurology.com/cidp
7. https://www.ncbi.nlm.nih.gov/books/NBK563249/
8. https://practicalneurology.com/diseases-diagnoses/neuromuscular/diagnosis-of-chronic-inflammatory-demyelinating-polyneuropathy/32112/
9. https://www.rarediseaseadvisor.com/news/sensory-cidp-treatable-immunotherapy-36-of-41-patients/
10. https://practicalneurology.com/articles/2024-apr/diagnosis-of-chronic-inflammatory-demyelinating-polyneuropathy
11. https://www.healthline.com/health/chronic-inflammatory-demyelinating-polyneuropathy-treatment
12. https://my.clevelandclinic.org/health/diseases/cidp-chronic-inflammatory-demyelinating-polyneuropathy
13. https://pmc.ncbi.nlm.nih.gov/articles/PMC8651975/
14. https://en.wikipedia.org/wiki/Chronic_inflammatory_demyelinating_polyneuropathy
15. https://pmc.ncbi.nlm.nih.gov/articles/PMC3487533/
16. https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2021.653734/full
17. https://www.rarediseaseadvisor.com/hcp-resource/chronic-inflammatory-demyelinating-polyneuropathy-signs-symptoms/
18. https://www.physio-pedia.com/Chronic_Inflammatory_Demyelinating_Polyneuropathy_(CIDP)
19. https://www.hopkinsmedicine.org/health/conditions-and-diseases/chronic-inflammatory-demyelinating-polyradiculoneuropathy
20. https://www.neurologylive.com/view/defining-typical-and-atypical-variants-of-cidp
21. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.890142/full
22. https://cadense.com/blogs/cadense-cares/first-symptoms-of-cidp
23. https://www.vaccineinjuryteam.com/blog/2023/november/first-symptoms-of-chronic-inflammatory-demyelina/
24. https://pubmed.ncbi.nlm.nih.gov/33660880/
25. http://www.jmatonline.com/PDF/262-269-PB-100-3.pdf
26. https://touchneurology.com/neuromuscular-diseases/journal-articles/new-treatments-for-chronic-inflammatory-demyelinating-polyneuropathy/